Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 4,337 shares, a decline of 24.5% from the February 12th total of 5,748 shares. Based on an average daily volume of 21,882 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 21,882 shares, the short-interest ratio is currently 0.2 days.

Alpha Tau Medical Price Performance

NASDAQ:DRTSW traded up $0.03 during mid-day trading on Friday, hitting $0.95. The company’s stock had a trading volume of 2,834 shares, compared to its average volume of 55,852. The business’s fifty day moving average is $0.97 and its two-hundred day moving average is $0.55. Alpha Tau Medical has a 1 year low of $0.13 and a 1 year high of $1.50.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.